Opko Health (OPK) Total Non-Current Liabilities (2010 - 2026)
Opko Health (OPK) reported Total Non-Current Liabilities of $503.8 million for Q1 2026, down 3.27% on a YoY basis from $520.8 million in Q1 2025, and down 2.61% quarter-over-quarter from $517.3 million in Q4 2025.
Opko Health (OPK) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Opko Health has reported Total Non-Current Liabilities for 17 years, with the latest figure at $503.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities fell 3.27% year-over-year to $503.8 million; the trailing twelve-month figure through Mar 2026 stood at $503.8 million (down 3.27% YoY), and the FY2025 full-year result was $517.3 million, down 19.38% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $503.8 million, down from $517.3 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $641.7 million in Q4 2024, with the low at $328.4 million in Q3 2022.
- Historically, Total Non-Current Liabilities has averaged $464.5 million across 5 years, with a median of $435.3 million in 2022.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities surged 55.76% — and 2025, when it dropped 19.38%.
- Opko Health's Total Non-Current Liabilities stood at $392.1 million in 2022, then climbed by 7.73% to $422.4 million in 2023, then jumped by 51.9% to $641.7 million in 2024, then declined by 19.38% to $517.3 million in 2025, then retreated by 2.61% to $503.8 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $503.8 million (Q1 2026), $517.3 million (Q4 2025), and $520.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 22.71 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 737.18 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Opko Health | 1.09 Bn | 747.11 Mn | 45.76 Mn | 503.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503.80 Mn |
| Dec 31, 2025 | 517.31 Mn |
| Sep 30, 2025 | 520.70 Mn |
| Jun 30, 2025 | 504.90 Mn |
| Mar 31, 2025 | 520.81 Mn |
| Dec 31, 2024 | 641.67 Mn |
| Sep 30, 2024 | 641.03 Mn |
| Jun 30, 2024 | 365.00 Mn |
| Mar 31, 2024 | 516.87 Mn |
| Dec 31, 2023 | 422.43 Mn |
| Sep 30, 2023 | 411.56 Mn |
| Jun 30, 2023 | 397.10 Mn |
| Mar 31, 2023 | 395.44 Mn |
| Dec 31, 2022 | 392.13 Mn |
| Sep 30, 2022 | 328.45 Mn |
| Jun 30, 2022 | 435.33 Mn |
| Mar 31, 2022 | 382.80 Mn |
| Dec 31, 2021 | 384.58 Mn |
| Sep 30, 2021 | 369.04 Mn |
| Jun 30, 2021 | 375.09 Mn |